Physiological and cytokine responses in IL-1 beta-deficient mice after zymosan-induced inflammation

被引:47
作者
Fantuzzi, G
Sacco, S
Ghezzi, P
Dinarello, CA
机构
[1] UNIV COLORADO, HLTH SCI CTR, DIV INFECT DIS, DENVER, CO 80262 USA
[2] MARIO NEGRI INST PHARMACOL RES, LAB NEUROIMMUNOL, I-20157 MILAN, ITALY
关键词
complement; interleukin-6; tumor necrosis factor; acute-phase response;
D O I
10.1152/ajpregu.1997.273.1.R400
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Interleukin (IL)-1 beta-deficient (IL-1 beta -/-) mice exhibited decreased zymosan-induced lethality and reduced production of IL-6 compared with wild-type controls (IL-1 beta +/+). In addition, IL-1 beta -/- mice had a diminished cellular infiltrate (33%) in the peritoneal cavity after zymosan. However, anorexia and hypoglycemia were not affected by the lack of IL-1 beta. The induction of corticosterone was only slightly reduced (14%) in IL-1 beta -/- mice. Peritoneal lavage fluid levels for IL-1 alpha, but not for tumor necrosis factor (TNF)-alpha, were also decreased. To evaluate the role of residual IL-1 alpha production in IL-1 beta -/- mice, we used IL-1-receptor antagonist (IL-1ra). In IL-1 beta +/+ mice, IL-1ra inhibited production of IL-6 after zymosan, without affecting TNF-cu synthesis. There was no further inhibitory effect of IL-1ra on IL-6 production in IL-1 beta -/- mice, suggesting no role for IL-1 alpha in zymosan-induced IL-6. Our results demonstrate that IL-1 beta plays a significant, although not exclusive, role in the physiological and cytokine responses to zymosan-mediated inflammation.
引用
收藏
页码:R400 / R406
页数:7
相关论文
共 33 条
[1]  
Aggarwal BB, 1996, EUR CYTOKINE NETW, V7, P93
[2]   COMPLEMENT ACTIVATION DURING SYSTEMIC LUPUS-ERYTHEMATOSUS - C3A AND C5A ANAPHYLATOXINS CIRCULATE DURING EXACERBATIONS OF DISEASE [J].
BELMONT, HM ;
HOPKINS, P ;
EDELSON, HS ;
KAPLAN, HB ;
LUDEWIG, R ;
WEISSMANN, G ;
ABRAMSON, S .
ARTHRITIS AND RHEUMATISM, 1986, 29 (09) :1085-1089
[3]   CACHECTIN AND TUMOR-NECROSIS-FACTOR AS 2 SIDES OF THE SAME BIOLOGICAL COIN [J].
BEUTLER, B ;
CERAMI, A .
NATURE, 1986, 320 (6063) :584-588
[4]  
COLIGAN JE, 1992, CURRENT PROTOCOLS IM, V1
[5]  
COLLINS PD, 1991, J IMMUNOL, V146, P677
[6]  
Czop J K, 1986, Adv Immunol, V38, P361, DOI 10.1016/S0065-2776(08)60011-5
[7]   A NEW NONISOTOPIC DETECTION SYSTEM FOR IMMUNOASSAYS [J].
DEAVER, DR .
NATURE, 1995, 377 (6551) :758-760
[8]   Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147
[9]  
DUCHATEAU J, 1984, AM REV RESPIR DIS, V130, P1058
[10]  
FANTUZZI G, 1995, J IMMUNOL, V155, P3552